Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mauna Kea Technologies installs first three Cellvizio systems and obtains key regulatory clearances in Brazil

Monday, 31 Mar 2014 12:00pm EDT 

Mauna Kea Technologies SA:Says its Cellvizio system is or will soon be available at three hospitals in Brazil: ICESP (Cancer Institute of the Sao Paulo University), INCA (National Cancer Institute in Rio de Janeiro), and FUGAST (Gastroenterology Institute of Rio Grande do Sul).Says ANVISA, National Health Surveillance Agency in Brazil, has cleared the company to sell its miniprobe for direct pancreatic cyst imaging, the AQ-Flex 19, as well as its first miniprobe for urology, UroFlex and its Optical Biopsy software platform, EVA, Endomicroscopy Virtual Assistant.